A panel of biopharmaceutical leaders convened at the Galien Forum discussed the impacts of the Inflation Reduction Act so far ...

Inc. ( an integrated pharmaceutical company dedicated to the worldwide development and commercialization of impactful ...

State Treasurer Deb Goldberg, Commissioner Jeffrey McCue of MA Department of Transitional Assistance, Suffolk County District Attorney Kevin Hayden, as well as several other state and local officials ...

The Greater Boston Food Bank (GBFB), the largest hunger-relief organization in New England, held its 19th annual Chain of Giving event, an annual tradition uniting elected officials, local advocates, ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and (Nasdaq: BIIB, Corporate headquarters: Cambridge, ...

Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointment of Douglas E. Williams, Ph.D., as Climb Bio’s Chair of its ...

After dosing with Cognition’s CT1812, study reports declines of 95% and higher in subgroup with below-median p-tau217.

The Lupus Research Alliance (LRA), the largest private funder of lupus research worldwide, today announced that a total of 33 studies, funded by the organization or supported by its clinical research ...